Depreciation of ATOSSA THERAPEUTICS, INC. from 31 Dec 2011 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
ATOSSA THERAPEUTICS, INC. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2011 to 31 Mar 2025.
  • ATOSSA THERAPEUTICS, INC. Depreciation for the quarter ending 31 Mar 2025 was $4,000, a 20% decline year-over-year.
  • ATOSSA THERAPEUTICS, INC. annual Depreciation for 2024 was $17,000, a 26% decline from 2023.
  • ATOSSA THERAPEUTICS, INC. annual Depreciation for 2023 was $23,000, a 188% increase from 2022.
  • ATOSSA THERAPEUTICS, INC. annual Depreciation for 2022 was $8,000, a 20% decline from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

ATOSSA THERAPEUTICS, INC. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $4,000 -$1,000 -20% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q1 2024 $5,000 +$2,000 +67% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q1 2023 $3,000 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q1 2018 $19,019 $2,725 -$6,937 -72% 01 Jan 2018 31 Mar 2018 10-Q 14 May 2018 2018 Q1
Q4 2017 $25,956 $2,967 -$33,643 -92% 01 Oct 2017 31 Dec 2017 10-K 28 Mar 2019 2018 FY
Q3 2017 $59,599 $4,554 -$25,144 -85% 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2017 2017 Q3
Q2 2017 $84,743 $8,773 -$23,961 -73% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 $108,704 $9,662 -$16,957 -64% 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018 2018 Q1
Q4 2016 $125,661 $36,610 +$22,692 +163% 01 Oct 2016 31 Dec 2016 10-K 08 Mar 2018 2017 FY
Q3 2016 $102,969 $29,698 -$2,922 -9% 01 Jul 2016 30 Sep 2016 10-Q 13 Nov 2017 2017 Q3
Q2 2016 $105,891 $32,734 +$19,456 +147% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017 2017 Q2
Q1 2016 $86,435 $26,619 +$13,341 +100% 01 Jan 2016 31 Mar 2016 10-Q 11 May 2017 2017 Q1
Q4 2015 $73,094 $13,918 -$65,300 -82% 01 Oct 2015 31 Dec 2015 10-K/A 21 Mar 2017 2016 FY
Q3 2015 $138,394 $32,620 +$7,977 +32% 01 Jul 2015 30 Sep 2015 10-Q/A 21 Mar 2017 2016 Q3
Q2 2015 $130,417 $13,278 -$6,586 -33% 01 Apr 2015 30 Jun 2015 10-Q/A 21 Mar 2017 2016 Q2
Q1 2015 $137,003 $13,278 -$7,893 -37% 01 Jan 2015 31 Mar 2015 10-Q/A 21 Mar 2017 2016 Q1
Q4 2014 $144,896 $79,218 +$58,950 +291% 01 Oct 2014 31 Dec 2014 10-K 30 Mar 2015 2014 FY
Q3 2014 $85,946 $24,643 -$2,522 -9.3% 01 Jul 2014 30 Sep 2014 10-Q 12 Nov 2014 2014 Q3
Q2 2014 $88,468 $19,864 -$10,804 -35% 01 Apr 2014 30 Jun 2014 10-Q 12 Aug 2014 2014 Q2
Q1 2014 $99,272 $21,171 +$16,302 +335% 01 Jan 2014 31 Mar 2014 10-Q 13 May 2015 2015 Q1
Q4 2013 $82,970 $20,268 01 Oct 2013 31 Dec 2013 10-K 30 Mar 2015 2014 FY
Q3 2013 $27,165 01 Jul 2013 30 Sep 2013 10-Q 12 Nov 2014 2014 Q3
Q2 2013 $30,668 01 Apr 2013 30 Jun 2013 10-Q 12 Aug 2014 2014 Q2
Q1 2013 $4,869 +$546 +13% 01 Jan 2013 31 Mar 2013 10-Q 14 May 2014 2014 Q1
Q1 2012 $4,323 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013 2013 Q1

ATOSSA THERAPEUTICS, INC. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $17,000 -$6,000 -26% 01 Jan 2024 31 Dec 2024 10-K 25 Mar 2025 2024 FY
2023 $23,000 +$15,000 +188% 01 Jan 2023 31 Dec 2023 10-K 25 Mar 2025 2024 FY
2022 $8,000 -$2,000 -20% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
2021 $10,000 -$9,000 -47% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2022 2021 FY
2020 $19,000 -$3,000 -14% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2022 2021 FY
2019 $22,000 +$8,000 +57% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
2018 $14,000 -$11,956 -46% 01 Jan 2018 31 Dec 2018 10-K 26 Mar 2020 2019 FY
2017 $25,956 -$99,705 -79% 01 Jan 2017 31 Dec 2017 10-K 28 Mar 2019 2018 FY
2016 $125,661 +$52,567 +72% 01 Jan 2016 31 Dec 2016 10-K 08 Mar 2018 2017 FY
2015 $73,094 -$71,802 -50% 01 Jan 2015 31 Dec 2015 10-K/A 21 Mar 2017 2016 FY
2014 $144,896 +$61,926 +75% 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2015 2014 FY
2013 $82,970 +$57,888 +231% 01 Jan 2013 31 Dec 2013 10-K 30 Mar 2015 2014 FY
2012 $25,082 +$21,162 +540% 01 Jan 2012 31 Dec 2012 10-K 27 Mar 2014 2013 FY
2011 $3,920 01 Jan 2011 31 Dec 2011 10-K 28 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.